Genomic profiling at a single center cracks the code in inborn errors of immunity

Area of Science:

• Immunology
• Genetics
• Medical Diagnostics

Background:

• Inborn errors of immunity (IEI) are genetic disorders causing immune dysregulation.
• Diagnosing monogenic immune defects often requires advanced genetic analysis.

Purpose of the Study:

• To evaluate the clinical utility of next-generation sequencing (NGS) and target gene panels (TGPs) in diagnosing IEI.
• To identify genetic variants in patients with unclassified antibody deficiency.

Main Methods:

• Reviewed clinical records, immune characteristics, and family histories of eight patients.
• Performed target gene panel (TGP) sequencing to detect pathogenic variants.

Main Results:

• Identified seven variants in genes including TNFRSF13B, CARMIL2, STAT1, STAT3, and ORAI1.
• Confirmed diagnoses, enabling proper prognostic assessment and tailored treatment strategies.
• Observed significant genetic heterogeneity and phenotypic variability in patients.

Conclusions:

• TGPs are effective tools for diagnosing IEI, facilitating personalized medicine.
• NGS improves patient outcomes by enabling precise diagnosis and treatment strategies for immune disorders.
• Comprehensive genetic testing is essential for understanding immune system dysfunction and advancing immunology.